Medulloblastomas are one of the most common childhood brain cancers. Group-3 medulloblastomas are particularly aggressive and ...

Researchers from the Francis Crick Institute and the Gulbenkian Institute for Molecular Medicine (GIMM) have shown that the ...

The Chanhassen-based company plans to use the funds on a randomized trial of its “sonodynamic therapy” for glioblastoma.

A BME team is putting a synthetic flag on tumors, then engineering a patient’s immune cells to find and eliminate cancer.

Discover upcoming breakthroughs in Type 1 Diabetes & B-cell disorder treatments, market growth to $24B by 2031, and key ...

The investigation demonstrated that dual targeting of DOT1L and EZH2 effectively prevented human GCB-DLBCL xenograft growth ...

Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer ...

Using a novel microscopy technique, researchers revealed how influenza viruses interact with host cells. The method enabled ...

A rapidly developed, dual-target chimeric antigen receptor T-cell therapy produced a 100% overall response rate in patients ...

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus.